Ptc Therapeutics (PTCT) news
Recent news
PTC Industries - Raises 18 bln rupees through qualified institutions placement
PTC Industries has raised ₹18 billion through a qualified institutional placement (QIP), a move aimed at strengthening its capital base and supporting ongoing expansion initiatives. The placement was oversubscribed, reflecting strong investor confidence in the company’s strategic direction and…
AInvest Wire · 1d agoAxis Capital raises PSB bid to EUR 3.20/share vs Bawag
Axis Capital Holdings Limited (AXS) has increased its bid for Permanent TSB Group Holdings plc (PTSB) to €3.20 per share, valuing the Irish retail bank at approximately €1.62 billion. The revised offer represents a significant step in the ongoing acquisition process, which has been recommended by…
AInvest Wire · 2d agoPatria Private Equity Trust PLC - Looking ahead, we expect meaningful realisation activity from portfolio in short term
Patria Private Equity Trust PLC (LSE: PPET) has indicated that it anticipates meaningful realisation activity from its portfolio in the short term. As a diversified private equity investment trust, PPET is managed by Patria Capital Partners LLP and seeks to qualify as an investment trust under UK…
AInvest Wire · 2d agoPTC Therapeutics, Inc.: RBC cuts target price to $75 from $85
RBC Capital Markets has revised its target price for PTC Therapeutics, Inc. (PTC) from $85 to $75, reflecting a 11.8% reduction in its valuation estimate for the biopharmaceutical company [1]. The adjustment follows a reassessment of the company’s near-term clinical and commercial outlook, though…
AInvest Wire · 6d agoPTC Industries opens QIP Oct. 6 at floor price INR 22,150/share
PTC Industries has launched a qualified institutional placement (QIP) on October 6, 2026, with an indicative floor price set at ₹22,150 per share. The QIP aims to raise up to ₹1,800 crore, representing an equity dilution of approximately 5.7% of the company’s pre-issue paid-up equity capital. The…
AInvest Wire · Oct 7, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.